vimarsana.com
Home
Live Updates
BTK Inhibitor–Associated AEs Can Influence Treatment Selection in MCL : vimarsana.com
BTK Inhibitor–Associated AEs Can Influence Treatment Selection in MCL
William Pearse, MD, discusses the roles of acalabrutinib and zanubrutinib in mantle cell lymphoma, as well as the adverse effect profiles of each agent.
Related Keywords
San Diego
,
California
,
United States
,
Williamb Pearse
,
,
University Of California
,
San Diego School Of Medicine
,
San Diego School
,
Nct04855695
,
William Pearse
,
D
,
Acalabrutinib
,
Zanubrutinib
,
Mantle Cell Lymphoma
,
Cmcl
,
vimarsana.com © 2020. All Rights Reserved.